Current surgical epidemiology of esophageal and gastric cancer;Aktuelle chirurgische epidemiologie des ösophagus-und magenkarzinoms in Deutschland

Viszeralchirurgie

Volumn 40, Issue 4, 2005, Pages 236-241

  Bollschweiler, Elfriede ^a   Ziegler, C ^a   Wolfgarten, E ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Epidemiology; Esophageal cancer; Etiology; Gastric cancer

Indexed keywords

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARDIA CARCINOMA; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; FRUIT; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TUMOR; HUMAN; LIFESTYLE; OBESITY; PROGNOSIS; REVIEW; SODIUM RESTRICTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER;

EID: 23844546575     PISSN: 14353067     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836650     Document Type: Review

References (25)

1. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I et al. Hospital volume and surgical mortality in the United States. The New England Journal of Medicine 2002; 346: 1128-1137
2. Hölscher AH, Metzger R, Brabender J, Vallböhmer D, Bollschweiler E. High volume centers - effect of case load on outcome in high-risk cancer surgery. Onkologie 2004; 8: 543-546
3. Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester T, Holscher A. High volume centers for esophagectomy: What is the number needed to achieve low postoperative mortality? Dis Esophagus 2004; 17: 310-314
4. Killeen S, O'Sullivan M, Coffey J, Kirwan W, Redmond H. Provider volume and outcomes for oncological procedures [In Process Citation]. Br J Surg 2005; 92: 389-402
5. Bollschweiler E, Hölscher A. Carcinoma of the esophagus - actual epidemiology in Germany. Onkologie 2001; 24: 180-184
6. Bareiss D, Stabenow R, Muller R, Eisinger B, Stegmaier C, Daubler P et al. Current epidemiology of carcinoma of the esophagus and cardia in Germany. Dtsch Med Wochenschr 2002; 127: 1367-1374
7. Siewert J, Hölscher A, Becker K, Gossner W. Kardiakarzinom. Versuch einer therapeutisch relevanten Klassifikation. Chirurg 1987; 58: 25-29
8. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549-555
9. Lagergren J, Bergström R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 18: 825-831
10. Wu A, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12: 721-732
11. Bollschweiler E, Wolfgarten E, Nowroth T, Rosendahl U, Mönig S, Hölscher A. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 2002; 128: 575-580
12. Chow W, Blot W, Vaughan T, Risch H, Gammon M, Stanford J et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150-155
13. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-890
14. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005; 96: 1-6
15. Sugiyama T. Development of gastric cancer associated with Helicobacter pylori infection. Cancer Chemother Pharmacol 2004; 54 (Suppl 1): S12-S20
16. Schandl L, Malfertheiner P, Ebert M. Prevention of gastric cancer by Helicobacter pylori eradication. Results from clinical intervention studies? Dig Dis 2002; 20: 18-22
17. Palli D, Russo A, Decarli A. Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control 2001; 12: 163-172
18. Wolfgarten E, Rosendahl U, Nowroth T, Leers J, Metzger R, Hölscher A et al. Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie 2001; 24: 546-551
19. Palli D, Russo A, Ottini L, Masala G, Saieva C, Amorosi A et al. Red meat, family history, and increased risk of gastric cancer with microsatellite instability. Cancer Res 2001; 61: 5415-5419
20. Wang H, Hsieh C, Antonioli D. Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). Cancer Causes Control 1994; 5: 573-578
21. Vaughan T, Farrow D, Hansten P, Chow W, Gammon M, Risch H et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev 1998; 7: 749-756
22. Bollschweiler E, Ell C. Plattenepithelkarzinom und Adenokarzinom des Ösophagus - Unterschiede in Epidemiologie, Tumorbiologie, Diagnostik und Prävention. Der Onkologe 2004; 10: 1178-1188
23. Bollschweiler E, Schröder W, Hölscher A, Siewert J. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 2000; 87: 1106-1110
24. Stein H, Lordick F, Siewert J. Osophaguskarzinom: Chirurgische und multimodale Therapie. Chirurgische Gastroenterologie 2004; 20: 13-20
25. Borch K, Jonsson B, Tarpila E, Franzen T, Berglund J, Kullman E et al. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg 2000; 87: 618-626